XML 23 R10.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Earnings Per Share | 6 Months Ended
--- | ---
Jun. 30, 2024
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The following table sets forth the computation of basic earnings per share and earnings per share, assuming dilution.
| Second Quarters |  | Six Months
| 2024 | 2023 (a) |  | 2024 (a) | 2023 (a)
Numerator (Dollars in Millions): |  |  |  |  |
Net Earnings | $ | 963 |  | $ | 984 |  |  | $ | 1,843 |  | $ | 1,958 |
Denominator (Units in Millions): |  |  |  |  |
Average Common Shares Outstanding | 1,944 |  | 2,020 |  |  | 1,951 |  | 2,037 |
Other Potentially Dilutive Common Shares | 4 |  | 5 |  |  | 4 |  | 5 |
Average Common Shares Outstanding, Assuming Dilution | 1,948 |  | 2,025 |  |  | 1,955 |  | 2,042 |
Net Earnings Per Share, Basic | $ | 0.50 |  | $ | 0.49 |  |  | $ | 0.94 |  | $ | 0.96 |
Net Earnings Per Share, Assuming Dilution | $ | 0.49 |  | $ | 0.49 |  |  | $ | 0.94 |  | $ | 0.96 |
(a) See Note 11, Revision of Prior Period Financial Statements. Basic earnings per share is based on the weighted-average number of shares of common stock outstanding. Earnings per share, assuming dilution, is based on the weighted-average number of shares of common stock outstanding and common stock equivalents adjusted for the effects of common stock that may be issued as a result of potentially dilutive instruments. CSX's potentially dilutive instruments are made up of equity awards including employee stock options, performance units and restricted stock units. When calculating diluted earnings per share, the potential shares that would be outstanding if all outstanding stock options were exercised are included. This number is different from outstanding stock options because it is offset by shares CSX could repurchase using the proceeds from these hypothetical exercises to obtain the common stock equivalent. The total average outstanding stock options that were excluded from the diluted earnings per share calculation because their effect was antidilutive is in the table below.
| Second Quarters |  | Six Months
| 2024 | 2023 |  | 2024 | 2023
Antidilutive Stock Options Excluded from Diluted EPS (Units in Millions) | 3 | 3 |  | 3 | 4
NOTE 2. Earnings Per Share, continued Share Repurchases During November 2023, the share repurchase program announced in July 2022 was completed and the Company began repurchasing shares under the $5 billion share repurchase program approved in October 2023. Total repurchase authority remaining was $4.0 billion as of June 30, 2024. Share repurchases may be made through a variety of methods including, but not limited to, open market purchases, purchases pursuant to Rule 10b5-1 plans, accelerated share repurchases and negotiated block purchases. The timing of share repurchases depends upon management's assessment of marketplace conditions and other factors, and the program remains subject to the discretion of the Board of Directors. Future share repurchases are expected to be funded by cash on hand, cash generated from operations and debt issuances. Shares are retired immediately upon repurchase. In accordance with the Equity Topic in the Accounting Standards Codification ("ASC"), the excess of repurchase price over par value is recorded in retained earnings. During second quarters and six months ended June 30, 2024 and June 30, 2023, the Company engaged in the following repurchase activities:
| Second Quarters |  | Six Months
| 2024 | 2023 |  | 2024 | 2023
Shares Repurchased (Millions) | 16 |  | 28 |  |  | 23 |  | 63 |
Cost of Shares (Dollars in Millions) | $ | 563 |  | $ | 863 |  |  | $ | 810 |  | $ | 1,930 |
The Inflation Reduction Act of 2022 imposes a nondeductible 1% excise tax on the net value of most share repurchases made after December 31, 2022. Excise tax commensurate with net share repurchases is reflected in equity and a corresponding liability for excise taxes payable is included in other current liabilities on the consolidated balance sheet. Amounts shown in the table above exclude the impact of this excise tax. Dividend Increase In February 2024, the Company's Board of Directors authorized a 9% increase in the quarterly cash dividend to $0.12 per common share effective March 2024.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration